NASDAQ
Liminal BioSciences Inc. (LMNL) has a current ratio of 4.09x as of Monday, May 25, 2026. This represents a 21.67% increase compared to its 12-month average of 3.36x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.